Abstract
Invasive and noninvasive arterial imaging are important techniques used to study atherosclerosis and, specifically, to evaluate the atherogenecity of triglyceride‐rich lipoproteins (TRL). Serial coronary angiography trials show significant benefit from lowering low‐density lipoprotein cholesterol (LDL‐C) which serves to retard lesion progression. Even with aggressive LDL‐C reduction, however, up to half of patients demonstrate continued progression of atherosclerosis. Angiographic studies reveal that lowering LDL‐C has the most impact on severe lesions, those ≥50% diameter stenosis, whereas TRL (and their apolipoprotein markers) have been identified as a driving factor behind progression of mild‐to‐moderate lesions <50% diameter stenosis. Quantitative coronary angiography (QCA) has demonstrated that progression of mild‐to‐moderate lesions are among the most significant predictors of clinical coronary events, and that lowering TRL reduces progression of coronary artery disease to the same degree as the lowering of LDL‐C.
Keywords: angiography, apolipoprotein C‐III, atherosclerosis, cholesterol, coronary artery, lipoprotein, low‐density lipoprotein, triglyceride, ultrasonography
Full Text
The Full Text of this article is available as a PDF (707.9 KB).
References
- 1. Blankenhorn DH, Hodis HN: Duff Memorial Lecture: Arterial imaging and atherosclerosis reversal. Arterioscler Thromb 1994; 14: 177–192 [DOI] [PubMed] [Google Scholar]
- 2. Hodis HN, Mack WJ, Azen SP, Alaupovic P, Pogoda JM, LaBree L, Hemphill LC, Kramsch DM, Blankenhorn DH: Triglyceride and cholesterol‐rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation 1994; 90: 42–49 [DOI] [PubMed] [Google Scholar]
- 3. Mack WJ, Krauss RM, Hodis HN: Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS): Treatment effects and relation to coronary angiographic progression. Arterioscler Thromb Vasc Biol 1996; 16: 697–704 [DOI] [PubMed] [Google Scholar]
- 4. Alaupovic P, Mack WJ, Knight‐Gibson C, Hodis HN: The role of triglyceride‐rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial. Arterioscler Thromb Vasc Biol 1997; 17: 715–722 [DOI] [PubMed] [Google Scholar]
- 5. Hodis HN, Mack WJ, Dunn M, Liu CR, Liu CH, Selzer RH, Krauss RM: Intermediate‐density lipoproteins and progression of carotid arterial wall intima‐media thickness. Circulation 1997; 95: 2022–2026 [DOI] [PubMed] [Google Scholar]
- 6. Blankenhorn DH, Azen SP, Kramsch DM, Mack WJ, Cashin‐Hemphill L, Hodis HN, DeBoer LWV, Mahrer PR, Masteller MJ, Vailas LI, Alaupovic P, Hirsch LJ: Coronary angiographic changes with lovastatin therapy: The Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med 1993; 119: 969–976 [DOI] [PubMed] [Google Scholar]
- 7. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, Alaupovic P, Kwong‐Fu H, Azen SP: Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: A randomized, controlled clinical trial. Ann Intern Med 1996; 124: 548–556 [DOI] [PubMed] [Google Scholar]
- 8. Alaupovic P: David Rubinstein Memorial Lecture: The biochemical and clinical significance of the interrelationship between very low density and high density lipoproteins. Can J Biochem 1981; 59: 565–579 [DOI] [PubMed] [Google Scholar]
- 9. Blankenhorn DH, Alaupovic P, Wickham E, Chin HP, Azen SP: Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts: Lipid and non‐lipid factors. Circulation 1990; 81: 470–476 [DOI] [PubMed] [Google Scholar]
- 10. Azen SP, Mack W, Cashin‐Hemphill L, LaBree L, Shircore A, Selzer RH, Blankenhorn DH, Hodis HN: Progression of coronary artery disease predicts clinical coronary events: Long‐term follow‐up from the Cholesterol Lowering Atherosclerosis Study. Circulation 1996; 93: 34–41 [DOI] [PubMed] [Google Scholar]
- 11. Hodis HN, Mack WJ: Triglyceride‐rich lipoproteins and the progression of coronary artery disease. Curr Opin Lipidol 1995; 6: 209–214 [DOI] [PubMed] [Google Scholar]
- 12. Mack WJ, Hodis HN, LaBree L, Liu CR, Liu CH, Selzer RH: Progression of carotid intima‐media thickness correlates with angiographic progression of coronary disease. Circulation 1996; 94: 1–122 8964107 [Google Scholar]
- 13. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CL, Liu CH, Azen SP: The role of carotid arterial intima‐media thickness in predicting clinical coronary events. Ann Intern Med 1998; 262–269 [DOI] [PubMed]
- 14. Ericsson CG, Hamsten A, Nilsson J, Grip L, Svane B, de Faire U: Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients. Lancet 1996; 347: 849–853 [DOI] [PubMed] [Google Scholar]
- 15. Frick MH, Syvanne M, Nieminen MS, Kauma H, Majahalme S, Virtanen V, Kesaniemi A, Pasternack A, Taskinen MR: Prevention of the angiographic progression of coronary and vein‐graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Circulation 1997; 96: 2137–2143 [DOI] [PubMed] [Google Scholar]